Cybin (HELP) Net Equity Issued and Repurchased (2020 - 2025)
Cybin (HELP) posted quarterly Net Equity Issued and Repurchased of $135.9 million for Q4 2025, up 1241.35% on a QoQ basis from $10.1 million in Q2 2025.
Cybin (HELP) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends
Cybin (HELP) has reported Net Equity Issued and Repurchased for 5 consecutive years, with $135.9 million the latest figure, recorded in Q4 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $135.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $175.2 million (changed N/A YoY) and the FY2022 annual result came in at $42.9 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased advanced to $135.9 million in Q4 2025 per HELP's latest filing, from $10.1 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for HELP reached as high as $135.9 million in Q4 2025 and fell as low as $2.5 million in Q4 2022.
- A 4-year average of $27.9 million and a median of $12.7 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased surged 4285.05% — and 2023, when it jumped 1045.56%.
- Year by year, Net Equity Issued and Repurchased stood at $25.0 million in 2021, then sank by 89.82% to $2.5 million in 2022, then soared by 1045.56% to $29.2 million in 2023, then soared by 365.61% to $135.9 million in 2025.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $135.9 million, $10.1 million, and $29.2 million for Q4 2025, Q2 2025, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 135.92 Mn |
| Dec 31, 2025 | 135.92 Mn |
| Jun 30, 2025 | 10.13 Mn |
| Jun 30, 2025 | 10.13 Mn |
| Dec 31, 2023 | 29.19 Mn |
| Dec 31, 2023 | 29.19 Mn |
| Sep 30, 2023 | 15.21 Mn |
| Sep 30, 2023 | 15.21 Mn |
| Jun 30, 2023 | 2.62 Mn |
| Jun 30, 2023 | 2.62 Mn |
| Dec 31, 2022 | 2.55 Mn |
| Dec 31, 2022 | 2.55 Mn |
| Feb 28, 2022 | 2.67 Mn |
| Feb 28, 2022 | 2.67 Mn |
| Sep 30, 2021 | 25.03 Mn |
| Sep 30, 2021 | 25.03 Mn |
| Dec 31, 2020 | 33.96 Mn |
| Dec 31, 2020 | 33.96 Mn |
| Sep 30, 2020 | -598,087.67 |
| Sep 30, 2020 | -598,087.67 |